Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
Notified -
Globe Newswire27-01-2025, 18:00
Regulatory filing for house dust mite allergy tablet 3-02-2023, 18:56